» Articles » PMID: 15731292

Synovial Tissue Inflammation in Early and Late Osteoarthritis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2005 Feb 26
PMID 15731292
Citations 390
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare selected immunohistological features of inflammation in synovial tissue from patients with early and late osteoarthritis (OA).

Methods: Synovial tissue samples were obtained from 10 patients with knee pain, normal radiographs, and arthroscopic manifestations of OA (early OA), and from 15 patients with OA undergoing knee joint arthroplasty (late OA). Conventional immunohistochemical techniques were used to measure microscopic manifestations of inflammation. The inflammatory cell infiltrate, blood vessel formation, and angiogenic factors, NF-kappaB activation, expression of tumour necrosis factor alpha (TNFalpha) and interleukin 1beta (IL1beta), and the presence of cyclo-oxygenase (COX)-1 and COX-2 were quantified. Fibroblast-like synoviocytes (FLS) were isolated from early and late OA tissue samples to compare in vitro production of prostaglandin E2 (PGE2)

Results: Synovial tissue from patients with early OA demonstrated significantly greater CD4+ (p = 0.017) and CD68+ (p<0.001) cell infiltration, blood vessel formation (p = 0.01), vascular endothelial growth factor (p = 0.001), and intercellular adhesion molecule-1 expression (p<0.001). Numbers of cells producing TNFalpha and IL1beta were also significantly greater in early OA (p<0.001). Manifestations of inflammation in early OA were associated with increased expression of the NF-kappaB1 (p<0.001) and RelA (p = 0.015) subunits, and with increased COX-2 expression (p = 0.04). Cytokine-induced PGE2 production by cultured FLS was similar in both groups.

Conclusion: Increased mononuclear cell infiltration and overexpression of mediators of inflammation were seen in early OA, compared with late OA. Isolated FLS were functionally similar in both groups, consistent with microenvironmental differences in the synovial tissue during different phases of OA. These observations may have important therapeutic implications for some patients during the early evolution of OA.

Citing Articles

Comparison of the effectiveness of intra-infrapatellar fat pad and intra-articular glucocorticoid injection in knee osteoarthritis patients with Hoffa's synovitis: protocol for a multicentre randomised controlled trial.

Chen Y, Lin J, Lin J, Gao T, Cai Q, Zhang C BMJ Open. 2025; 15(1):e087785.

PMID: 39880431 PMC: 11781145. DOI: 10.1136/bmjopen-2024-087785.


Ketogenic Diet-Associated Worsening of Osteoarthritis Histologic Secerity, Increased Pain Sensitivity and Gut Microbiome Dysbiosis in Mice.

Dyson G, Barrett M, Schlupp L, Prinz E, Hannebut N, Szymczak A ACR Open Rheumatol. 2025; 7(1):e11794.

PMID: 39853943 PMC: 11760994. DOI: 10.1002/acr2.11794.


Patient-Specific Variability in Interleukin-6 and Myeloperoxidase Responses in Osteoarthritis: Insights from Synthetic Data and Clustering Analysis.

Coleman L, Byrne J, Edwards S, OHara R J Pers Med. 2025; 15(1).

PMID: 39852209 PMC: 11766770. DOI: 10.3390/jpm15010017.


Single-cell profiling uncovers synovial fibroblast subpopulations associated with chondrocyte injury in osteoarthritis.

Liu Z, Sun Y, Pan J, Guo K, Tang Z, Wang X Front Endocrinol (Lausanne). 2024; 15:1479909.

PMID: 39720254 PMC: 11666364. DOI: 10.3389/fendo.2024.1479909.


Synovial mast cells and osteoarthritis: Current understandings and future perspectives.

Hao G, Han S, Xiao Z, Shen J, Zhao Y, Hao Q Heliyon. 2024; 10(24):e41003.

PMID: 39720069 PMC: 11665477. DOI: 10.1016/j.heliyon.2024.e41003.


References
1.
Iagnocco A, Coari G . Usefulness of high resolution US in the evaluation of effusion in osteoarthritic first carpometacarpal joint. Scand J Rheumatol. 2000; 29(3):170-3. DOI: 10.1080/030097400750002049. View

2.
Cunnane G, Bjork L, Ulfgren A, Lindblad S, FitzGerald O, Bresnihan B . Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements. Ann Rheum Dis. 1999; 58(8):493-9. PMC: 1752933. DOI: 10.1136/ard.58.8.493. View

3.
Young L, Katrib A, Cuello C, Vollmer-Conna U, Bertouch J, Roberts-Thomson P . Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study. Arthritis Rheum. 2001; 44(2):343-50. DOI: 10.1002/1529-0131(200102)44:2<343::AID-ANR52>3.0.CO;2-Q. View

4.
Murphy E, McEvoy A, Conneely O, Bresnihan B, FitzGerald O . Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum. 2001; 44(4):782-93. DOI: 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.0.CO;2-H. View

5.
Ballara S, Taylor P, Reusch P, Marme D, Feldmann M, Maini R . Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 2001; 44(9):2055-64. DOI: 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2. View